Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Epigenetics Remove


April 2014
Su Sa Fr Th We Tu Mo
20 19 18 17 16 15 14

epigenetics Press Releases

  + XML/RSS  



By tebu-bio
tebu-bio is pleased to announce their agreement with EpiCypher™ to distribute their innovative product range throughout Europe

By Biovision Inc
BioVision is very excited to announce the launch of the first edition of this latest brochure titled: “Epigenetics Research Tools”.

By BPS Bioscience, Inc.
First commercially available NSD kits for inhibitor screening and profiling applications

By BPS Bioscience, Inc.
Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug...

By BPS Bioscience, Inc.
BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs).

By Zymo Research
Zymo Research offers genome-wide Next-Gen sequencing services for genetic, epigenetic, and expression analysis

By BioVision, Inc.
BioVision recently introduced Nexturastat A, a highly potent and selective Histone Deacetylase 6 (HDAC6) inhibitor. This unique inhibitor is currently being marketed for research purposes exclusively by BioVision.

By AnaSpec EGT Group
Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry

By Sara Pierre - Communication Manager
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

By Sara Pierre - Communication Manager
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

All Press Releases

By tebu-bio
tebu-bio is pleased to announce their agreement with EpiCypher™ to distribute their innovative product range throughout Europe

By Biovision Inc
BioVision is very excited to announce the launch of the first edition of this latest brochure titled: “Epigenetics Research Tools”.

By BPS Bioscience, Inc.
First commercially available NSD kits for inhibitor screening and profiling applications

By Cambridge Healthtech Institute
Led by global industry pioneers, Clinical Genomics & Informatics Europe will provide research teams with technologies and strategies for Exome Sequencing, High-Scale Computing, RNA Sequencing, Genome Informatics, Epigenetics and Digital Detection.

By BPS Bioscience, Inc.
Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug...

By BPS Bioscience, Inc.
BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs).

By Zymo Research
Zymo Research offers genome-wide Next-Gen sequencing services for genetic, epigenetic, and expression analysis

By ReportReserve
ReportReserve announces the inclusion of its new report published by Global Kalorama Information.

By BioVision, Inc.
BioVision recently introduced Nexturastat A, a highly potent and selective Histone Deacetylase 6 (HDAC6) inhibitor. This unique inhibitor is currently being marketed for research purposes exclusively by BioVision.

By AnaSpec EGT Group
Anti-5-Methylcyidine from Clone 33D3 can be used in applications such as Methylated DNA Immunoprecipitation (MeDIP), MeDIP-on-chip assay, immunofluorescence, flow cytometry and immunohistochemistry

By Sara Pierre - Communication Manager
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

By Sara Pierre - Communication Manager
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

By Russ Curran
Jus International is holding a unique event -- A Blueprint for Abundant Living -- being held at Boston’s Marriott Copley Hotel on January 15, 2011, at 7 p.m.

By AnaSpec
AnaSpec, Eurogentec Group is pleased to offer anti-5-methylcytidine (Clone 33D3), Eurogentec’s most popular monoclonal antibody, for use in epigenetics research.

By AbboMax, inc.
AbboMax offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27 for the epigenetics research. .

By Insight Pharma Reports
CHI’s makes available its Insight Pharma Report on current and projected markets for epigenetic diagnostic and therapeutic products.

By Mary Ann Liebert, Inc., publishers
Increasing numbers of research studies clearly demonstrate that genetics alone cannot explain the diversity of living organisms, reports Genetic Engineering & Biotechnology News (GEN).

By Joe Walsh
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report that presents information about the quickly emerging worldwide epigenetics market.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share